Page last updated: 2024-09-02

glutarylphenylalanine-4-nitroanilide and Neoplasms

glutarylphenylalanine-4-nitroanilide has been researched along with Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andreoli, R; Bianchi, MG; Bussolati, O; Chiu, M; Giuliani, N; Sabino, C; Taurino, G1
Li, Z; Liu, Y; Sun, L; Wang, L; Yuan, S; Zhao, T1

Reviews

1 review(s) available for glutarylphenylalanine-4-nitroanilide and Neoplasms

ArticleYear
The role of ASCT2 in cancer: A review.
    European journal of pharmacology, 2018, Oct-15, Volume: 837

    Topics: Amino Acid Transport System ASC; Dipeptides; DNA-Binding Proteins; Humans; MicroRNAs; Minor Histocompatibility Antigens; Neoplasms; Proto-Oncogene Proteins c-myc; Ubiquitin-Protein Ligases

2018

Other Studies

1 other study(ies) available for glutarylphenylalanine-4-nitroanilide and Neoplasms

ArticleYear
GPNA inhibits the sodium-independent transport system L for neutral amino acids.
    Amino acids, 2017, Volume: 49, Issue:8

    Topics: Adaptor Proteins, Signal Transducing; Amino Acids, Neutral; Cell Proliferation; Dipeptides; Humans; Large Neutral Amino Acid-Transporter 1; Neoplasms; Tumor Cells, Cultured

2017